Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease

Topic: Brain proteins, microglia and lab models

Sporadic or late-onset Alzheimer's disease (AD) is expected to affect 50% of individuals reaching 85 years of age. The most significant genetic risk factor for late-onset AD is the e4 allele of APOE gene encoding apolipoprotein E, a lipid carrier shown to modulate brain amyloid burden. Recent genome-wide association studies have uncovered additional single nucleotide polymorphisms (SNPs) linked to AD susceptibility, including those in the CLU and BIN1 genes encoding for clusterin (CLU) and the bridging integrator 1 (BIN1) proteins, respectively. Because CLU has been implicated in brain amyloid-β (Aβ) clearance in mouse models of amyloid deposition, we sought to investigate whether an AD-linked SNP in the CLU gene altered Aβ42 biomarker levels in the cerebrospinal fluid (CSF). Instead, we found that the CLU rs11136000 SNP modified CSF levels of the microtubule-associated protein Tau in AD patients. We also found that an intracellular form of CLU (iCLU) was upregulated in the brain of Tau overexpressing Tg4510 mice, but not in Tg2576 amyloid mouse model. By overexpressing iCLU and Tau in cell culture systems we discovered that iCLU was a Tau-interacting protein and that iCLU associated with brain-specific isoforms of BIN1, also recently identified as a Tau-binding protein. Through expression analysis of CLU and BIN1 variants, we found that CLU and BIN1 interacted via their coiled-coil motifs. In co-immunoprecipitation studies using human brain tissue, we showed that iCLU and the major BIN1 isoform expressed in neurons were associated with modified Tau species found in AD. Finally, we showed that expression of certain coding CLU variants linked to AD risk led to increased levels of iCLU. Together, our findings suggest that iCLU and BIN1 interaction might impact Tau function in neurons and uncover potential new mechanisms underlying the etiology of Tau pathology in AD.

@article{zhou2014-25051234,
  author  = {Zhou, Y. and Hayashi, I. and Wong, J. and Tugusheva, K. and Renger, J. J. and Zerbinatti, C.},
  title   = {{Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease}},
  journal = {PloS one},
  year    = {2014},
  doi     = {10.1371/journal.pone.0103187},
  pmid    = {25051234},
  url     = {https://doi.org/10.1371/journal.pone.0103187}
}

Key findings

• The most significant genetic risk factor for late-onset AD is the e4 allele of APOE gene encoding apolipoprotein E, a lipid carrier shown to modulate brain amyloid burden.
• Instead, we found that the CLU rs11136000 SNP modified CSF levels of the microtubule-associated protein Tau in AD patients.
• By overexpressing iCLU and Tau in cell culture systems we discovered that iCLU was a Tau-interacting protein and that iCLU associated with brain-specific isoforms of BIN1, also recently identified as a Tau-binding protein.
• Through expression analysis of CLU and BIN1 variants, we found that CLU and BIN1 interacted via their coiled-coil motifs.
• In co-immunoprecipitation studies using human brain tissue, we showed that iCLU and the major BIN1 isoform expressed in neurons were associated with modified Tau species found in AD.

New to this subject? Start with our plain-English guide: Genetics →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1371/journal.pone.0103187
• PubMed: 25051234
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Genetics

• Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology Journal of Alzheimer's disease : JAD · 2014-01-01 · usefulness score 43/100
• Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America · 1994-11-01 · usefulness score 49/100
• Tau protein aggregation is associated with cellular senescence in the brain Aging cell · 2018-10-11 · usefulness score 41/100
• Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis The Journal of biological chemistry · 2012-04-26 · usefulness score 48/100
• The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels Archives of general psychiatry · 2011-02-01 · usefulness score 57/100
• A human-specific de novo protein-coding gene associated with human brain functions PLoS computational biology · 2010-03-26 · usefulness score 40/100

Similar studies

• Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ 2017 · Genetics
• CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk 2026 · Risk genes beyond APOE
• Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease 2010 · Mild cognitive impairment
• Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease 2021 · Biomarkers
• Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease 2023 · Biomarkers
• Clusterin as a therapeutic target 2017 · Risk genes beyond APOE

More on Genetics

• A review that covers this ground Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment Free radical biology & medicine · 2007-06-13 · usefulness score 36/100
• Newest in this subject APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer’s Disease Model Research Square · 2026-10-31 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Integrative systems biology identifies shared neuroimmune co-expression programmes across pulmonary tuberculosis and Alzheimer's disease Research Square · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Genetics →